Your browser doesn't support javascript.
loading
Multi-drug hybrid delivery systems with distinct release profiles based on gelatin/collagen containing vesicles derived from block copolymers.
Brey Gil, Viviane S; Brey Gil, Camila S; Goulart, Gisele Assis Castro; Oréfice, Rodrigo L.
Afiliação
  • Brey Gil VS; Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais CEP 31270-901, Brazil.
  • Brey Gil CS; Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais CEP 31270-901, Brazil.
  • Goulart GAC; Department of Pharmaceutics, Faculty of Pharmacy, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais CEP 31270-901, Brazil.
  • Oréfice RL; Department of Metallurgical and Materials Engineering, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais CEP 31270-901, Brazil. Electronic address: rorefice@demet.ufmg.br.
Int J Biol Macromol ; 139: 967-974, 2019 Oct 15.
Article em En | MEDLINE | ID: mdl-31401279
ABSTRACT
Hybrid delivery systems can release multiple drugs with different profiles and have several applications, including skin dressing. In this work, the co-solvent technique was used for the preparation of nanometric vesicles based on poly(styrene-b-ethylene oxide) block copolymer (BCPVs) containing adapalene (AD). The BCPVs were incorporated into collagen and gelatin matrices together with free AD and silver sulfadiazine (SSD). The AD content of BCPVs and their release capacity were analyzed by using ultraviolet-visible spectroscopy (UV-Vis). The gelatin and collagen matrices were evaluated for their ability to release AD and SSD through an in vitro release study. The obtained results confirmed that the production of empty and AD-loaded BCPVs was viable. The degree of AD encapsulation in BCPVs was 9.0% and the in vitro test revealed a constant, slow, and prolonged release of AD content from AD-loaded BCPVs. The combination of free and encapsulated multiple drugs in hybrid delivery systems based on gelatin and collagen matrices was shown to act as a skin dressing that combined the progressive release of large amounts of drugs within the first hours of use (to restrict infection) with a more prolonged and slow release of AD to enhance skin healing.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Poliestirenos / Portadores de Fármacos / Colágeno / Liberação Controlada de Fármacos / Gelatina Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Poliestirenos / Portadores de Fármacos / Colágeno / Liberação Controlada de Fármacos / Gelatina Idioma: En Ano de publicação: 2019 Tipo de documento: Article